Form 8-K - Current report:
SEC Accession No. 0001558370-25-000167
Filing Date
2025-01-13
Accepted
2025-01-13 16:25:13
Documents
17
Period of Report
2025-01-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K chrs-20250113x8k.htm   iXBRL 8-K 42447
2 EX-99.1 chrs-20250113xex99d1.htm EX-99.1 2798
3 GRAPHIC chrs-20250113xex99d1g001.jpg GRAPHIC 178454
  Complete submission text file 0001558370-25-000167.txt   450098

Data Files

Seq Description Document Type Size
4 EX-101.SCH chrs-20250113.xsd EX-101.SCH 4536
5 EX-101.DEF chrs-20250113_def.xml EX-101.DEF 3158
6 EX-101.LAB chrs-20250113_lab.xml EX-101.LAB 12264
7 EX-101.PRE chrs-20250113_pre.xml EX-101.PRE 11151
19 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20250113x8k_htm.xml XML 4903
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36721 | Film No.: 25526637
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)